Full Text View
Tabular View
No Study Results Posted
Related Studies
Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)
This study has been completed.
Study NCT00338936   Information provided by Novartis
First Received: June 16, 2006   Last Updated: October 16, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Valsartan + Hydrochlorothiazide
Additional drug interventions recognized in this trial
Hydrochlorothiazide
Valsartan
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services